Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Per Bo Larsen"'
Autor:
K. S. Khuenl-Brady, Matthias Eikermann, Martine E. Prins, Andreas W. Sielenkämper, F Pühringer, Christopher Rex, Per Bo Larsen, Casper Claudius
Publikováno v:
Anesthesiology. 109:188-197
Background Sugammadex (Org 25969), a novel, selective relaxant binding agent, was specifically designed to rapidly reverse rocuronium-induced neuromuscular blockade. The efficacy and safety of sugammadex for the reversal of profound, high-dose rocuro
Autor:
Jørgen Viby-Mogensen, Doris Østergaard, Per Bo Larsen, Iben Foss Sorgenfrei, Martine E. Prins, Jakob Stensballe, Kathrine Norrild
Publikováno v:
Anesthesiology. 104:667-674
Background Sugammadex (Org 25969) forms a complex with steroidal neuromuscular blocking agents, thereby reversing neuromuscular block. This study investigated the dose-response relation, safety, and pharmacokinetics of sugammadex to reverse rocuroniu
Autor:
Iben F, Sorgenfrei, Kathrine, Norrild, Per Bo, Larsen, Jakob, Stensballe, Doris, Ostergaard, Martine E, Prins, Jørgen, Viby-Mogensen
Publikováno v:
Anesthesiology. 104(4)
Sugammadex (Org 25969) forms a complex with steroidal neuromuscular blocking agents, thereby reversing neuromuscular block. This study investigated the dose-response relation, safety, and pharmacokinetics of sugammadex to reverse rocuronium-induced b
Publikováno v:
Ugeskrift for laeger. 168(12)
Publikováno v:
Ugeskrift for laeger. 164(10)